The future of psychiatric research: Genomes and neural circuits

Science

Volumn 327, Issue 5973, 2010, Pages 1580-1581

  Akil, Huda ^a   Brenner, Sydney ^b   Kandel, Eric ^c   Kendler, Kenneth S ^d   King, Mary Claire ^e   Scolnick, Edward ^f   Watson, James D ^g   Zoghbi, Huda Y ^h  

^a UNIVERSITY OF MICHIGAN   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^g Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

^h BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE TREATMENT; GENOME; NERVOUS SYSTEM DISORDER; NEUROLOGY; PSYCHOLOGY; RESEARCH WORK;

AFFECT; ALZHEIMER DISEASE; AUTISM; DEPRESSION; DIFFUSION TENSOR IMAGING; DISABILITY; DISEASE TRANSMISSION; DRUG RESEARCH; EMOTION; EPIGENETICS; FRAGILE X SYNDROME; GENE DISRUPTION; GENE FUNCTION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOME; GENOMICS; HEALTH CARE COST; HUMAN; HUNTINGTON CHOREA; INTRAUTERINE INFECTION; MALNUTRITION; MEDICAL RESEARCH; MENTAL DISEASE; MOOD DISORDER; NERVE CELL NETWORK; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; RETT SYNDROME; SCHIZOPHRENIA; SEQUENCE ANALYSIS; SHORT SURVEY; STRESS; ANIMAL; ARTICLE; BRAIN; DNA SEQUENCE; ECONOMICS; FORECASTING; GENETIC PREDISPOSITION; GENETICS; HUMAN GENOME; NERVE TRACT; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; BRAIN; FORECASTING; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GENOMICS; HUMANS; MENTAL DISORDERS; NEURAL PATHWAYS; SEQUENCE ANALYSIS, DNA;

EID: 77950231051     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1188654     Document Type: Short Survey

References (20)

1. W. W. Eaton et at., Epidemiol. Rev. 30, 1 (2008).
2. J. A. Lieberman et al., Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators, N. Engl. J. Med. 353,1209 (2005).
3. G. Gartlehner et al, Ann. Intern. Med. 149, 734 (2008).
4. H. Jaaro-Peled et al, Trends Neurosci. 32, 485 (2009).
5. A. Bailey et al, Psychol. Med. 25, 63 (1995).
6. I.I. Gottesman, Schizophrenia Genesis: The Origins of Madness (W. H. Freeman, New York, 1991).
7. P. F. Sullivan, K. S. Kendler, M. C. Neale, Arch. Gen. Psychiatry 60, 1187(2003).
8. E. L. Messias, C. Y. Chen, W. W. Eaton, Psychiatr. Clin. North Am. 30, 323(2007).
9. J. M. McClellan, E. Susser, M.-C. King, Br. J. Psychiatry 190, 194 (2007).
10. P. S. Tarpey et al, Nat. Genet. 41, 535 (2009).
11. E. H. Cook Jr., S. W. Scherer, Nature 455, 919 (2008).
12. H. S. Mayberg et al, Neuron 45, 651 (2005).
13. S. G. Shah, H. Klumpp, M. Angstadt, P. J. Nathan, K. L. Phan, J. Psychiatry Neurosci. 34, 296 (2009).
14. L. R. Baxter Jr. et al, Arch. Gen. Psychiatry 49, 681 (1992).
15. A. Berndt, O. Yizhar, L. A. Gunaydin, P. Hegemann, K. Deisseroth, Nat. Neurosci. 12, 229 (2009).
16. E. M. Tan et al, Neuron 51,157 (2006).
17. D. Le Bihan et al, J. Magn. Reson. Imaging 13, 534 (2001).
18. R. Bernard et al, J. Neurosci. Methods 178, 46 (2009).
19. M. Fagiolini, C. L. Jensen, F. A. Champagne, Curr. Opin. Neurobiol. 19, 207 (2009).
20. J. N. MacLean, B. O. Watson, G. B. Aaron, R. Yuste, Neuron 48, 811 (2005).